Literature DB >> 24880650

Genetic variations in the KIR gene family may contribute to susceptibility to ankylosing spondylitis: a meta-analysis.

Hai-Ning Zuo1, Zhi-Long Wang, Dao-Ran Cui, Da-Jiang Xin.   

Abstract

The present meta-analysis of relevant case-control studies was conducted to investigate the possible relationships between genetic variations in the killer cell immunoglobulin-like receptor (KIR) gene clusters of the human KIR gene family and susceptibility to ankylosing spondylitis (AS). The following electronic databases were searched for relevant articles without language restrictions: the Web of Science, the Cochrane Library Database, PubMed, EMBASE, CINAHL, the Chinese Biomedical Database (CBM) and Chinese National Knowledge Infrastructure (CNKI) databases, covering all papers published until 2013. STATA statistical software was adopted in this meta-analysis as well. We also calculated the crude odds ratios (OR) and its 95% confidence intervals (95 % CI). Seven case-control studies with 1,004 patients diagnosed with AS and 2,138 healthy cases were implicated in our meta-analysis, and 15 genes in the KIR gene family were also evaluated. The results of our meta-analysis show statistical significance between the genetic variations in the KIR2DL1, KIR2DS4, KIR2DS5 and KIR3DS1 genes and an increased susceptibility to AS (KIR2DL1: OR 7.82, 95% CI 3.87-15.81, P< 0.001; KIR2DS4: OR 1.91, 95% CI 1.16-3.13, P = 0.010; KIR2DS5: OR1.51, 95% CI 1.14-2.01, P = 0.004; KIR3DS1: OR 1.58, 95% CI 1.34-1.86, P< 0.001; respectively). However, we failed to found positive correlations between other genes and susceptibility to AS (all P >0.05). The current meta-analysis provides reliable evidence that genetic variations in the KIR gene family may contribute to susceptibility to AS, especially for the KIR2DL1, KIR2DS4, KIR2DS5 and KIR3DS1 genes.

Entities:  

Year:  2014        PMID: 24880650     DOI: 10.1007/s11033-014-3402-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

Review 1.  Global prevalence of ankylosing spondylitis.

Authors:  Linda E Dean; Gareth T Jones; Alan G MacDonald; Christina Downham; Roger D Sturrock; Gary J Macfarlane
Journal:  Rheumatology (Oxford)       Date:  2013-12-09       Impact factor: 7.580

2.  No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.

Authors:  J McCappin; D Harvey; B P Wordsworth; D Middleton
Journal:  Tissue Antigens       Date:  2009-10-28

3.  Association between ED in ankylosing spondylitis: a population-based study.

Authors:  S-D Chung; Y-K Chen; S-P Liu; H-C Lin
Journal:  Int J Impot Res       Date:  2013-04-04       Impact factor: 2.896

4.  Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.

Authors:  Tahereh Mousavi; Hadi Poormoghim; Maziar Moradi; Nader Tajik; Farhad Shahsavar; Behnam Asadifar
Journal:  Iran J Immunol       Date:  2010-06       Impact factor: 1.603

5.  Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

Authors:  Yu-Lian Jiao; Bing-Chang Zhang; Li You; Jian-Feng Li; Jie Zhang; Chun-Yan Ma; Bin Cui; Lai-Cheng Wang; Zi-Jiang Chen; Yue-Ran Zhao
Journal:  J Clin Immunol       Date:  2010-07-21       Impact factor: 8.317

Review 6.  Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.

Authors:  Kerry S Campbell; Amanda K Purdy
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

Review 7.  Pathogenesis of ankylosing spondylitis.

Authors:  Lai-Shan Tam; Jieruo Gu; David Yu
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

8.  Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.

Authors:  Simona Sivori; Michela Falco; Lorenzo Moretta; Alessandro Moretta
Journal:  Trends Immunol       Date:  2010-07-12       Impact factor: 16.687

9.  Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.

Authors:  Yu-Lian Jiao; Chun-Yan Ma; Lai-Cheng Wang; Bin Cui; Jie Zhang; Li You; Zi-Jiang Chen; Jian-Feng Li; Yue-Ran Zhao
Journal:  J Clin Immunol       Date:  2008-02-23       Impact factor: 8.317

10.  Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.

Authors:  D Harvey; J J Pointon; C Sleator; A Meenagh; C Farrar; J Y Sun; D Senitzer; D Middleton; M A Brown; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  2008-11-19       Impact factor: 19.103

View more
  3 in total

1.  Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis.

Authors:  R Díaz-Peña; J R Vidal-Castiñeira; J Mulero; A Sánchez; R Queiro; C López-Larrea
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

2.  Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis.

Authors:  Hui-Ling Liang; Shu-Juan Ma; Hong-Zhuan Tan
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

3.  Non-classical human leucocyte antigens in ankylosing spondylitis: possible association with HLA-E and HLA-F.

Authors:  Margarida Rodrigues Santos; Ana Rita Couto; Iris Foroni; Bruno Filipe Bettencourt; Zhixiu Li; Raquel Meneses; Lawrie Wheeler; Joaquim Pereira; Fernando Pimentel-Santos; João Eurico Fonseca; Helena Alves; António Martinho; Manuela Lima; Matthew A Brown; Jácome Bruges-Armas
Journal:  RMD Open       Date:  2018-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.